238 related articles for article (PubMed ID: 25333522)
1. Non-genetic direct reprogramming and biomimetic platforms in a preliminary study for adipose-derived stem cells into corneal endothelia-like cells.
Dai Y; Guo Y; Wang C; Liu Q; Yang Y; Li S; Guo X; Lian R; Yu R; Liu H; Chen J
PLoS One; 2014; 9(10):e109856. PubMed ID: 25333522
[TBL] [Abstract][Full Text] [Related]
2. Cocktail of Chemical Compounds and Recombinant Proteins Robustly Promote the Stemness of Adipose-Derived Stem Cells.
Guo Y; Yu Q; Mathew S; Lian R; Xue Y; Cui Z; Li S; Zhu D; Han Y; Zeng Q; Liu S; Chen J
Cell Reprogram; 2017 Dec; 19(6):363-371. PubMed ID: 29215942
[TBL] [Abstract][Full Text] [Related]
3. Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells.
Ahmed TA; Shousha WG; Abdo SM; Mohamed IK; El-Badri N
Cell Physiol Biochem; 2020 Apr; 54(2):271-286. PubMed ID: 32233339
[TBL] [Abstract][Full Text] [Related]
4. Induction of Expandable Adipose-Derived Mesenchymal Stem Cells from Aged Mesenchymal Stem Cells by a Synthetic Self-Replicating RNA.
Miyagi-Shiohira C; Nakashima Y; Kobayashi N; Kitamura S; Saitoh I; Watanabe M; Noguchi H
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404192
[TBL] [Abstract][Full Text] [Related]
5. Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.
Kim JS; Choi HW; Choi S; Seo HG; Moon SH; Chung HM; Do JT
Stem Cells Dev; 2014 Nov; 23(21):2637-48. PubMed ID: 24892478
[TBL] [Abstract][Full Text] [Related]
6. Reprogramming of mouse fibroblasts into induced pluripotent stem cells with Nanog.
Moon JH; Yun W; Kim J; Hyeon S; Kang PJ; Park G; Kim A; Oh S; Whang KY; Kim DW; Yoon BS; You S
Biochem Biophys Res Commun; 2013 Feb; 431(3):444-9. PubMed ID: 23333380
[TBL] [Abstract][Full Text] [Related]
7. Characterization of porcine partially reprogrammed iPSCs from adipose-derived stem cells.
Wei C; Li X; Zhang P; Zhang Y; Liu T; Jiang S; Han F; Zhang Y
Reproduction; 2015 May; 149(5):485-96. PubMed ID: 25646510
[TBL] [Abstract][Full Text] [Related]
8. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S
Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429
[TBL] [Abstract][Full Text] [Related]
9. Efficient reprogramming of naïve-like induced pluripotent stem cells from porcine adipose-derived stem cells with a feeder-independent and serum-free system.
Zhang Y; Wei C; Zhang P; Li X; Liu T; Pu Y; Li Y; Cao Z; Cao H; Liu Y; Zhang X; Zhang Y
PLoS One; 2014; 9(1):e85089. PubMed ID: 24465482
[TBL] [Abstract][Full Text] [Related]
10. Adult stem and progenitor cells.
Geraerts M; Verfaillie CM
Adv Biochem Eng Biotechnol; 2009; 114():1-21. PubMed ID: 19373451
[TBL] [Abstract][Full Text] [Related]
11. Generation of OCT4-EGFP, NANOG-tdTomato dual reporter human induced pluripotent stem cell line, KKUi001-A, using the CRISPR/Cas9 system.
Lee M; Choi NY; Park S; Bang JS; Lee Y; Jeong D; Ham S; Lim S; Kim KH; Ko K
Stem Cell Res; 2020 Oct; 48():101943. PubMed ID: 32777770
[TBL] [Abstract][Full Text] [Related]
12. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
[TBL] [Abstract][Full Text] [Related]
13. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
15. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
17. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
[TBL] [Abstract][Full Text] [Related]
18. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
19. Identification of Oct4-activating compounds that enhance reprogramming efficiency.
Li W; Tian E; Chen ZX; Sun G; Ye P; Yang S; Lu D; Xie J; Ho TV; Tsark WM; Wang C; Horne DA; Riggs AD; Yip ML; Shi Y
Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20853-8. PubMed ID: 23213213
[TBL] [Abstract][Full Text] [Related]
20. Changes in the expression pattern of mesenchymal and pluripotent markers in human adipose-derived stem cells.
Park E; Patel AN
Cell Biol Int; 2010 Oct; 34(10):979-84. PubMed ID: 20446919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
